Literature DB >> 12719552

Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein.

John M Thomas1, William B Klimstra, Kate D Ryman, Hans W Heidner.   

Abstract

Alphavirus-based expression vectors commonly use a duplicated 26S promoter to drive expression of a foreign gene. Here we describe an expression strategy in which the foreign sequences are linked to the gene encoding the 2A protease of foot-and-mouth disease virus and then inserted in frame between the capsid and E3 genes of Sindbis virus. During replication, the 2A fusion protein is synthesized as a component of the viral structural polyprotein that is then released by intramolecular cleavages mediated by the capsid and 2A proteases. Recombinant Sindbis viruses that expressed fusion proteins composed of 2A linked to the green fluorescent protein (GFP) and to the VP7 protein of bluetongue virus were constructed. Viruses engineered to express GFP and VP7 from a duplicate 26S promoter were also constructed. All four viruses expressed the transgene and grew to similar titers in cultured cells. However, the GFP/2A- and VP7/2A-expressing viruses displayed greater expression stability and were less attenuated in newborn mice than the cognate double-subgenomic promoter-based viruses. By combining the two expression strategies, we constructed bivalent viruses that incorporated and expressed both transgenes. The bivalent viruses grew to lower titers in cultured cells and were essentially avirulent in newborn mice. Groups of mice were vaccinated with each VP7- and VP7/2A-expressing virus, and antibody responses to native VP7 were measured in an indirect enzyme-linked immunosorbent assay. Despite their genetic and phenotypic differences, all viruses induced similarly high titers of VP7-specific antibodies. These results demonstrate that 2A fusion protein-expressing alphaviruses may be particularly well suited for applications that require enduring expression of a single protein or coexpression of two alternative proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719552      PMCID: PMC154044          DOI: 10.1128/jvi.77.10.5598-5606.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Alphavirus expression vectors.

Authors:  S Schlesinger
Journal:  Adv Virus Res       Date:  2000       Impact factor: 9.937

2.  Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genome.

Authors:  Marco Vignuzzi; Sylvie Gerbaud; Sylvie van der Werf; Nicolas Escriou
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 3.  Alphavirus vectors and vaccination.

Authors:  Jonathan O Rayner; Sergey A Dryga; Kurt I Kamrud
Journal:  Rev Med Virol       Date:  2002 Sep-Oct       Impact factor: 6.989

Review 4.  Alphavirus vectors for gene expression and vaccines.

Authors:  S Schlesinger; T W Dubensky
Journal:  Curr Opin Biotechnol       Date:  1999-10       Impact factor: 9.740

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.

Authors:  P Pushko; J Geisbert; M Parker; P Jahrling; J Smith
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins.

Authors:  C M Rice; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences.

Authors:  Michelle L L Donnelly; Lorraine E Hughes; Garry Luke; Heidi Mendoza; Edwin Ten Dam; David Gani; Martin D Ryan
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

9.  Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12.

Authors:  B H Robertson; M J Grubman; G N Weddell; D M Moore; J D Welsh; T Fischer; D J Dowbenko; D G Yansura; B Small; D G Kleid
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

10.  Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.

Authors:  Udeni B R Balasuriya; Hans W Heidner; Nancy L Davis; Heike M Wagner; Pamela J Hullinger; Jodi F Hedges; Jacqueline C Williams; Robert E Johnston; W David Wilson; Irwin K Liu; N James MacLachlan
Journal:  Vaccine       Date:  2002-02-22       Impact factor: 3.641

View more
  28 in total

1.  Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo.

Authors:  Pong-Yu Huang; Jih-Huong Guo; Lih-Hwa Hwang
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

2.  Electroporation of Alphavirus RNA Translational Reporters into Fibroblastic and Myeloid Cells as a Tool to Study the Innate Immune System.

Authors:  Christina L Gardner; Derek W Trobaugh; Kate D Ryman; William B Klimstra
Journal:  Methods Mol Biol       Date:  2016

3.  Role of TSPAN9 in Alphavirus Entry and Early Endosomes.

Authors:  Katie M Stiles; Margaret Kielian
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

5.  Double subgenomic alphaviruses expressing multiple fluorescent proteins using a Rhopalosiphum padi virus internal ribosome entry site element.

Authors:  Michael R Wiley; Lisa O Roberts; Zach N Adelman; Kevin M Myles
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

6.  Development of infectious cDNA clones of Salmonid alphavirus subtype 3.

Authors:  Marius Karlsen; Stephane Villoing; Karl F Ottem; Espen Rimstad; Are Nylund
Journal:  BMC Res Notes       Date:  2010-09-21

7.  In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions.

Authors:  Aihua Zheng; Mahadevaiah Umashankar; Margaret Kielian
Journal:  PLoS Pathog       Date:  2010-10-21       Impact factor: 6.823

8.  Recombinant Sindbis virus vectors designed to express protective antigen of Bacillus anthracis protect animals from anthrax and display synergy with ciprofloxacin.

Authors:  John M Thomas; Scott T Moen; Bryan T Gnade; Diego A Vargas-Inchaustegui; Sheri M Foltz; Giovanni Suarez; Hans W Heidner; Rolf König; Ashok K Chopra; Johnny W Peterson
Journal:  Clin Vaccine Immunol       Date:  2009-09-16

9.  IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells.

Authors:  Eugenia Volkova; Elena Frolova; Justin R Darwin; Naomi L Forrester; Scott C Weaver; Ilya Frolov
Journal:  Virology       Date:  2008-05-22       Impact factor: 3.616

10.  Neurons and oligodendrocytes in the mouse brain differ in their ability to replicate Semliki Forest virus.

Authors:  Rennos Fragkoudis; Nele Tamberg; Ricky Siu; Kaja Kiiver; Alain Kohl; Andres Merits; John K Fazakerley
Journal:  J Neurovirol       Date:  2008-12-24       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.